関連する実験動画
Updated: Jul 25, 2026

11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
アンチトロンビンIIIに特異的な作用を持つヘパリン類である
Lancet (London, England)
|January 15, 1977
まとめ
新しいヘパリンアナログは,抗トロンビンIIIの活性を選択的にインビオで強化し,静脈血栓症の予防に潜在力を提供します. このアナログは,従来のヘパリンとは異なり,全体的な凝固に最小限の影響を及ぼします.
科学分野:
- 薬理学 薬理学とは
- バイオケミストリー バイオケミストリー
- トロンボシス研究研究
背景:
- ヘパリンは,広く使用されている抗凝固剤です.
- 安全性プロファイルが向上した抗凝固剤の開発は極めて重要です.
- ヘパリン類は,標的型治療効果の可能性を秘めている.
研究 の 目的:
- ヘパリンと半合成ヘパリンアナログのインビボおよびインビトロ効果を比較する.
- ヘパリンアナログの抗血栓的可能性を評価する.
主な方法:
- ヘパリン活性とカオリン・セファリン凝固時間 (K.C.C.T.) を測定するインビトロアッセイ. ) を実施する.
- アンチトロンビンIII増強とK.C.C.T.T.を評価するインビボ試験 親体投与後に.
- ヘパリンとそのアナログの比較.
主要な成果:
- ヘパリンアナログは,特定のヘパリンアッセイとK.C.C.T.に最小限のインビトロ効果を示した. ヘパリンと比較すると.
- In vivoでは,同類薬は,ヘパリンと類似した,Antithrombin IIIを著しく強化した.
- ヘパリンアナログはK.C.C.T.に有意な影響を及ぼさなかった. in vivo. in vivo. in vivo. 生体内で. 生体内で. 生体内で. 生体内で.
結論:
- ヘパリンアナログは,選択的にアンチトロンビンIIIを活体内で強化する.
- この選択的作用は,静脈血栓症の予防に潜在的に有利なプロファイルを示唆しています.
- アナログは,全球凝固パラメータへの影響が軽減された抗血栓効果を提供することがあります.
関連する概念動画
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

